Eric Blomme

Dr. Eric Blomme

AbbVie, 1 North Waukegan Road, R46R/AP9A-224, North Chicago, IL 60064, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YYYi Yang
Yi Yang
KKKenneth Kowalkowski
Kenneth Kowalkowski
RCRita Ciurlionis
Rita Ciurlionis
WBWayne R. Buck
Wayne R. Buck
Keith GlaserKeith Glaser
Keith Glaser
Eric BlommeEric Blomme
Eric Blomme
Cancer therapies targeting the vascular endothelial growth factor (VEGF) signaling pathway can lead to renal damage by disrupting the glomerular ultrafiltration apparatus. The objective of the current study was to identify sensitive biomarkers for VEGF inhibition-induced glomerular changes in rats. Male Sprague-Dawley rats were administered an experimental VEGF receptor (VEGFR) inhibitor, ABT-123, for seven days to investigate the correlation of several biomarkers with microscopic and ultrastructural changes. Glomeruli obtained by laser capture microdissection were also subjected to gene expression analysis to investigate the underlying molecular events of VEGFR inhibition in glomerulus. ABT-123 induced characteristic glomerular ultrastructural changes in rats, including fusion of podocyte foot processes, the presence of subendothelial electron-dense deposits, and swelling and loss of fenestrations in glomerular endothelium. The subtle morphological changes cannot be detected with light microscopy or by changes in standard clinical chemistry and urinalysis. However, urinary albumin increased 44-fold as early as Day three. Urinary β2-microglobulin levels were also increased. Other urinary biomarkers that are typically associated with tubular injury were not significantly impacted. Such patterns in urinary biomarkers can provide valuable diagnostic insight to VEGF inhibition therapy-induced glomeruli injuries.



1 August 2015 in The Veterinary Journal
Verified
Journal Article
Closed access
BHBradley A. Hooker
Bradley A. Hooker
Eric BlommeEric Blomme
Eric Blomme